欧力士
IX
36.89
+0.38
+1.04%
欧力士
US · IX
#545 按市值排名
上市于 1970
36.89
+0.38
+1.04%
实时 - 追踪5344个代码 - 心跳于444秒前
· 2026-10-16 19:30
最新新闻
-
IX Biopharma Rides DoD-Backed Wafermine Push and U.S. Expansion StrategyTipRanks · 2026/9/23
-
公司公告
4: Netskope | 4: Statement of changes in beneficial ownership of securities-10% Owner Lightspeed Venture Partners IX, L.P.SEC · 2026/7/10
-
IX Biopharma Details Wafermine Milestones and U.S. Compounding Push Ahead of AGMTipRanks · 2026/10/10
-
公司公告
4: Boundless Bio | 4: Statement of changes in beneficial ownership of securities-10% Owner ARCH Venture Fund IX, L.P.SEC · 2026/7/7
-
IX Biopharma Advances Wafermine as U.S. Opens Rare Military Emergency Use PathwayTipRanks · 2026/9/7
-
评级变动
Phillip Securities Remains a Buy on IX Biopharma Ltd. (42C)TipRanks · 2026/9/9
-
公司公告
ORIX: (Progress of Matters for Disclosure) Notice Regarding Transfer of Equity Interest (change in subsidiary): IX NTI Holdings (U.S. PE Investment: NC)JPX · 2026/6/30
-
公司公告
IX Biopharma: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-Cessation of Substantial Shareholder - Anson Properties Pte. Ltd.SGX · 2026/9/10
-
评级变动
BofA Securities Maintains ORIX(IX.US) With Hold Rating\u5e02\u573a\u8d44\u8baf · 2026/8/10
-
Analyst Maintains Buy on IX Biopharma, Sees Post-FY26 Transition Driving Strong FY27+ Rebound and Keeps DCF-Based S$1.00 Target PriceTipRanks · 2026/9/1
-
IX Biopharma Moves to Convert A$1.7 Million Debt Into EquityTipRanks · 2026/10/5
-
公司公告
Netskope | 4: Statement of changes in beneficial ownership of securities-10% Owner Lightspeed Venture Partners IX, L.P.SEC · 2026/9/15
-
评级变动
BofA Securities Initiates ORIX(IX.US) With Hold Rating\u5e02\u573a\u8d44\u8baf · 2024/11/12
-
AXP Energy Exits Syrian Block IX Farm-In to Refocus on U.S. OperationsTipRanks · 2026/8/31
新闻标题为自动聚合内容,未经我们团队独立核实或编辑。
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
欧力士 讨论区 0 条评论